International Urology and Nephrology

, Volume 49, Issue 1, pp 113–121 | Cite as

Clinical outcomes of acute kidney injury developing outside the hospital in elderly

  • K. Turgutalp
  • S. Bardak
  • M. Horoz
  • İ. Helvacı
  • S. Demir
  • A. A. Kiykim
Nephrology - Original Paper



Although various studies have improved our knowledge about the clinical features and outcomes of acute kidney injury developing in the hospital (AKI-DI) in elderly subjects, data about acute kidney injury developing outside the hospital (AKI-DO) in elderly patients (age ≥ 65 years) are still extremely limited. This study was performed to investigate prevalence, clinical outcomes, hospital cost and related factors of AKI-DO in elderly and very elderly patients.


We conducted a prospective, observational study in patients (aged ≥ 65 years) who were admitted to our center between May 01, 2012, and May 01, 2013. Subjects with AKI-DO were divided into two groups as “elderly” (group 1, 65–75 years old) and “very elderly” (group 2, >75 years old). Control group (group 3) consisted of the hospitalized patients aged 65 years and older with normal serum creatinine level. In-hospital outcomes and 6-month outcomes were recorded. Rehospitalization rate within 6 months of discharge was noted. Hospital costs and mortality rates of each group were investigated. Risk factors for AKI-DO were determined.


The incidence of AKI-DO that required hospitalization in elderly and very elderly patients was 5.8 % (136/2324) and 11 % (100/905), respectively (p < 0.001), with an overall incidence of 7.3 % (236/3229). Chronic kidney disease (CKD) was developed in 43.4 % of group 1 and 67 % of group 2 within the 6 months of discharge (p < 0.001). Progression to CKD was significantly lower in the control group than in groups 1 and 2 (p < 0.001). Mortality rates for groups 1, 2 and 3 were 23.5 % (n = 32), 31 % (n = 31) and 4.2 % (n = 8), respectively (p < 0.05). Rehospitalization rate within the 6 months of discharge for the groups with AKI-DO was higher than for the control group (p < 0.001). Hospital cost of groups 1 and 2 was significantly higher than that of the control group (p < 0.001). Nonsteroidal anti-inflammatory drugs (NSAIDs) (OR: 6.839, 95 % CI = 4.392–10.648), angiotensin-converting enzyme inhibitors (ACEI) (OR: 7.846, 95 % CI = 5.161–11.928), angiotensin receptor blockers (ARB) (OR: 6.466, 95 % CI = 4.813–8.917), radiocontrast agents (OR: 8.850, 95 % CI = 5.857–13.372), hypertension (OR: 4.244, 95 % CI = 2.729–6.600), diabetes mellitus (OR: 2.303, 95 % CI = 1.411–3.761), heart failure (OR: 3.647, 95 % CI = 2.276–5.844) and presence of infection (OR: 3.149, 95 % CI = 1.696–5.845) were found as the risk factors for AKI-DO in elderly patients (p < 0.001 for all). Patients with AKI-DO had higher 6-month mortality rate (HR 1.721, 95 % CI: 1.451–2.043, p < 0.001). Mortality risk increased 0.519 times at 20th day.


The incidence of AKI-DO requiring hospitalization is higher in very elderly patients than elderly ones, especially in male gender. Use of ACEI, ARB, NSAID and radiocontrast agents is the main risk factors for the development of AKI-DO in the elderly.


Acute kidney injury Cost Elderly Gender Outcome Rehospitalization 


Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Supplementary material

11255_2016_1431_MOESM1_ESM.docx (12 kb)
Supplementary material 1 (DOCX 12 kb)


  1. 1.
    Ross MM, Fisher R, Maclean MJ (2010) End-of-life care for seniors: the development of a national guide. J Palliat Care 16:47–53Google Scholar
  2. 2.
    Rosner M, Abdel-Rahman E, Williams ME (2010) Geriatric nephrology: responding to a growing challenge. Clin J Am Soc Nephrol 5:936–942. doi: 10.2215/CJN.08731209 CrossRefPubMedGoogle Scholar
  3. 3.
    Chertow GM, Burdick E, Honour M, Bonventre JV, Bates DW (2005) Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol 16(11):3365–3370CrossRefPubMedGoogle Scholar
  4. 4.
    Chronopoulos A, Cruz DN, Ronco C (2010) Hospital-acquired acute kidney injury in the elderly. Nat Rev Nephrol 6:141–149. doi: 10.1038/nrneph.2009.234 CrossRefPubMedGoogle Scholar
  5. 5.
    Obialo CI, Okonofua EC, Tayade AS, Riley LJ (2000) Epidemiology of de novo acute renal failure in hospitalized African Americans: comparing community-acquired vs hospital-acquired disease. Arch Intern Med 160(9):1309–1313. doi: 10.1001/archinte.160.9.1309 CrossRefPubMedGoogle Scholar
  6. 6.
    Talabani B, Zouwail S, Pyart RD, Meran S, Riley SG, Phillips AO (2014) Epidemiology and outcome of community-acquired acute kidney injury. Nephrology (Carlton) 19(5):282–287. doi: 10.1111/nep.12221 CrossRefGoogle Scholar
  7. 7.
    Kellum JA, Lameire N, KDIGO AKI Guideline Work Group (2013) Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1). Crit Care 17(1):204. doi: 10.1186/cc11454 CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150(9):604–612. doi: 10.7326/0003-4819-150-9-200905050-00006 CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    USRDS Annual Report (2013) Acute kidney injury. Am J Kidney Dis 61:e97–e108CrossRefGoogle Scholar
  10. 10.
    Kaufman J, Dhakal M, Patel B, Hamburger R (1991) Community-acquired acute renal failure. Am J Kidney Dis 17:191–198CrossRefPubMedGoogle Scholar
  11. 11.
    Liano F, Pascual J (1996) Epidemiology of acute renal failure: a prospective, multicenter, community-based study. Madrid acute renal failure study group. Kidney Int 50(3):811–818CrossRefPubMedGoogle Scholar
  12. 12.
    Feest TG, Round A, Hamad S (1993) Incidence of severe acute renal failure in adults: results of a community based study. BMJ 306:481–483CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Akposso K, Hertig A, Couprie R, Flahaut A, Alberti C, Karras GA, Haymann JP, Costa De Beauregard MA, Lahlou A, Rondeau E, Sraer JD (2000) Acute renal failure in patients over 80 years old: 25-years’ experience. Intensive Care Med 26:400–406CrossRefPubMedGoogle Scholar
  14. 14.
    Coca SG (2010) Acute kidney injury in elderly persons. Am J Kidney Dis 56:122–131. doi: 10.1053/j.ajkd.2009.12.034 CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Ungprasert P, Cheungpasitporn W, Crowson CS, Matteson EL (2015) Individual non-steroidal anti-inflammatory drugs and risk of acute kidney injury: a systematic review and meta-analysis of observational studies. Eur J Intern Med 26(4):285–291. doi: 10.1016/j.ejim.2015.03.008 CrossRefPubMedGoogle Scholar
  16. 16.
    Wu X, Zhang W, Ren H, Chen X, Xie J, Chen N (2014) Diuretics associated acute kidney injury: clinical and pathological analysis. Ren Fail 36(7):1051–1055. doi: 10.3109/0886022X.2014.917560 CrossRefPubMedGoogle Scholar
  17. 17.
    Chao CT, Tsai HB, Wu CY, Hsu NC, Lin YF, Chen JS, Hung KY (2015) Cross-sectional study of the association between functional status and acute kidney injury in geriatric patients. BMC Nephrol 16:186. doi: 10.1186/s12882-015-0181-7 CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Schissler MM, Zaidi S, Kumar H, Deo D, Brier ME, McLeish KR (2013) Characteristics and outcomes in community-acquired versus hospital-acquired acute kidney ınjury. Nephrology (Carlton) 18(3):183–187. doi: 10.1111/nep.12036 CrossRefGoogle Scholar
  19. 19.
    Der Mesropian PJ, Kalamaras JS, Eisele G, Phelps KR, Asif A, Mathew RO (2014) Long-term outcomes of community-acquired versus hospital-acquired acute kidney injury: a retrospective analysis. Clin Nephrol 81(3):174–184. doi: 10.5414/CN108153 CrossRefGoogle Scholar
  20. 20.
    Wonnacott A, Meran S, Amphlett B, Talabani B, Phillips A (2014) Epidemiology and outcomes in community-acquired versus hospital-acquired AKI. CJASN 9(6):1007–1014. doi: 10.2215/CJN.07920713 CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Dreischulte T, Morales DR, Bell S, Guthrie B (2015) Combined use of nonsteroidal anti-inflammatory drugs with diuretics and/or renin-angiotensin system inhibitors in the community increases the risk of acute kidney injury. Kidney Int 88(2):396–403. doi: 10.1038/ki.2015.101 CrossRefPubMedGoogle Scholar
  22. 22.
    Schmitt R, Coca S, Kanbay M, Tinetti ME, Cantley LG, Parikh CR (2008) Recovery of kidney function after acute kidney injury in the elderly: a systematic review and meta-analysis. Am J Kidney Dis 2:262–271. doi: 10.1053/j.ajkd.2008.03.005 CrossRefGoogle Scholar
  23. 23.
    Lo LJ, Go AS, Chertow GM, McCulloch CE, Fan D, Ordonez JD, Hsu CY (2009) Dialysis-requiring acute renal failure increases the risk of progressive chronic kidney disease. Kidney Int 76:893–899. doi: 10.1038/ki.2009.289 CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Hsu CY, Chertow GM, McCulloch CE, Fan D, Ordoñez JD, Go AS (2009) Nonrecovery of kidney function and death after acute on chronic renal failure. Clin J Am Soc Nephrol 4:891–898. doi: 10.2215/CJN.05571008 CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Bucaloiu ID, Kirchner HL, Norfolk ER, Hartle JE 2nd, Perkins RM (2012) Increased risk of death and de novo chronic kidney disease following reversible acute kidney injury. Kidney Int 81:477–485. doi: 10.1038/ki.2011.405 CrossRefPubMedGoogle Scholar
  26. 26.
    Albright RC, Smelser JM, McCarthy JT, Homburger HA, Bergstralh EJ, Larson TS (2000) Patient survival and renal recovery in acute renal failure: randomized comparison of cellulose acetate and polysulfone membrane dialyzers. Mayo Clin Proc 75:1141–1147CrossRefPubMedGoogle Scholar
  27. 27.
    Wald R, Quinn RR, Luo J, Li P, Scales DC, Mamdani MM, Ray JG (2009) University of Toronto acute kidney ınjury research group. Chronic dialysis and death among survivors of acute kidney injury requiring dialysis. JAMA 302:1179–1185. doi: 10.1001/jama.2009.1322 CrossRefPubMedGoogle Scholar
  28. 28.
    Tomlinson LA, Wheeler DC (2014) Chronic kidney disease and the uremic syndrome. In: Johnson RJ, Feehally J, Floege J (eds) Comprehensive clinical nephrology, 5th edn. Elsevier, Philadelphia, pp 942–948Google Scholar
  29. 29.
    Dasta JF, Kane-Gill SL, Durtsch AJ, Pathak DS, Kellum JA (2008) Costs and outcomes of acute kidney injury (AKI) following cardiac surgery. Nephrol Dial Transplant 23:1970–1974. doi: 10.1093/ndt/gfm908 CrossRefPubMedGoogle Scholar
  30. 30.
    Kerr M, Bedford M, Matthews B, O’Donoghue D (2014) The economic impact of acute kidney injury in England. Nephrol Dial Transplant 29(7):1362–1368. doi: 10.1093/ndt/gfu016 CrossRefPubMedGoogle Scholar
  31. 31.
    Bedford M, Stevens PE, Wheeler TW, Farmer CK (2014) What is the real impact of acute kidney injury? BMC Nephrol 15:95. doi: 10.1186/1471-2369-15-95 CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2016

Authors and Affiliations

  • K. Turgutalp
    • 1
  • S. Bardak
    • 1
  • M. Horoz
    • 2
  • İ. Helvacı
    • 3
  • S. Demir
    • 1
  • A. A. Kiykim
    • 1
  1. 1.Division of Nephrology, Department of Internal Medicine, School of MedicineMersin UniversityMersinTurkey
  2. 2.Division of Nephrology, Department of Internal Medicine, School of MedicineIstanbul Bahcesehir UniversityIstanbulTurkey
  3. 3.Silifke School of Applied Technology and Management, Department of Business Information Management and BiostatisticMersin UniversitySilifke, MersinTurkey

Personalised recommendations